Warning: The Trends for This Stock Look Negative Right Now

Northrop Grumman Corporation (NYSE:NOC) — This aerospace and defense company is the third-largest producer of military arms and equipment in the world. About 90% of its revenue is from defense plus a large U.S. government IT service.

Standard & Poor’s estimates that sales are likely to rise 3% in 2017 and 5% in 2018. But in late-January S&P reiterated their three-star “hold” on the stock and lowered their 12-month target price to $245 from $280.

This reduction places a price-to-earnings value of 20X their 2017 EPS estimate of $12.11 and is above the five- and 10-year average due to the election of President Donald Trump and the likely increase in U.S. government orders in 2017.

However, S&P cut their 2018 EPS due to lower guidance from management.

Now, with the consensus expecting $12.18 but with just 2% revenue growth projected in 2017 EPS and guidance at $11.30-$11.60, holders of NOC stock should consider this stock as a “cash cow” candidate.

In addition its dividend yield is only about 1.5%, which does not support holding the stock for income.

Technically, NOC stock is consolidating within a right triangle.

However, lower-than-average buying and two CBR Sell signals from my indicator are not favorable for the bulls. The 20-day moving average (green line) is crossing down through the 50-day moving average (blue line) for trend line sell signal with a minimum target of $228 to $220. MACD is slightly negative. I’m not suggesting that this stock be shorted, but neither would I suggest owning it at the current price.

— Sam Collins, Trade of the Day

The One Stock That Could Make You a Marijuana Millionaire [sponsor]
FDA approval and a pipeline of breakthrough marijuana medicines are about to send this stock soaring another 1,303%, making millionaires out of many early shareholders. But time is running out for you to get in on the ground floor. This Special Report will give you all the details, absolutely free.

Source: Investor Place